- Title
- Doctors and drug companies: is the dangerous liaison drawing to an end?
- Creator
- Moynihan, Ray
- Relation
- Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen Vol. 103, Issue 3, p. 141-148
- Publisher Link
- http://dx.doi.org/10.1016/j.zefq.2009.03.022
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2009
- Description
- The Introduction and Overview will contain a bold statement of the essay themes. Next the section on Entanglement will look at the many forms of doctor-drug company relationships, and the evidence for how these can distort practice. Selling Sickness will briefly explore the way doctor-drug company relationships are important to the widening of boundaries of treatable illness. And finally, Disclosure to Disentanglement will look at self-regulatory and statutory attempts around the world to get more independence in the relationship between doctors and drug companies.
- Subject
- conflict of interests; medicalisation; pharmaceutical industry; key opinion leaders; disease mongering; continuing medical education; CME
- Identifier
- uon:7167
- Identifier
- http://hdl.handle.net/1959.13/806620
- Identifier
- ISSN:1865-9217
- Hits: 798
- Visitors: 967
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|